Enogene focuses on developing a wide range of antibodies. The product portfolio of the company includes antibodies (monoclonal and polyclonal), recombinant protein, fluorescence reagents, signal inhibitors and activators, transfection reagents, and cell biology kits. In addition, it also offers services in antibody development, anti-cancer antibody activity evaluation, toxicology, drug screening, and preclinical pharmacology studies.
Visit Website